Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in ...

The entire 36-week data for the remaining subjects in the trial is anticipated in the second quarter of this year.

Morgan Stanley has initiated coverage on U.S. packaged food industry stocks with a cautionary but in-line outlook, according ...

"I would argue the folks closer to the operational side know better than we do, and I want to make sure that it's not all ...

CEBU-BASED fuel retailer Top Line Business Development Corp. (Topline) has secured approval from the Securities and Exchange Commission (SEC) for its planned initial public offering (IPO).  “Our ...

IntroductionI got to experience a VW Virtus 1.0 TSI AT Topline. While there is the official review and a few other ownership ...

BiomX announced a series of financings with total gross proceeds of approximately $12 million to support completion of Phase 2b ...

DNOW’s Q4 results showed slight growth, but challenges remain. Learn why DNOW stock faces short-term hurdles like soft demand ...

Two pivotal trials of the aldosterone synthase inhibitor have shown positive results for lorundrostat in uncontrolled and ...